These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37540942)

  • 61. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
    Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI
    Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Towards stage specific treatments: effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia.
    Rapado-Castro M; Berk M; Venugopal K; Bush AI; Dodd S; Dean OM
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():69-75. PubMed ID: 25315856
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The therapeutic effect of N-acetylcysteine as an add-on to methadone maintenance therapy medication in outpatients with substance use disorders: A randomized, double-blind, placebo-controlled clinical trial.
    Padoei F; Mamsharifi P; Hazegh P; Boroumand H; Ostadmohammady F; Abbaszadeh-Mashkani S; Banafshe HR; Matini AH; Ghaderi A; Dehkohneh SG
    Brain Behav; 2023 Jan; 13(1):e2823. PubMed ID: 36448959
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fluoxetine versus placebo in posttraumatic stress disorder.
    Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
    J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
    [TBL] [Abstract][Full Text] [Related]  

  • 65. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial.
    Bloch MH; Panza KE; Grant JE; Pittenger C; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):231-40. PubMed ID: 23452680
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.
    Abdallah CG; Roache JD; Gueorguieva R; Averill LA; Young-McCaughan S; Shiroma PR; Purohit P; Brundige A; Murff W; Ahn KH; Sherif MA; Baltutis EJ; Ranganathan M; D'Souza D; Martini B; Southwick SM; Petrakis IL; Burson RR; Guthmiller KB; López-Roca AL; Lautenschlager KA; McCallin JP; Hoch MB; Timchenko A; Souza SE; Bryant CE; Mintz J; Litz BT; Williamson DE; Keane TM; Peterson AL; Krystal JH
    Neuropsychopharmacology; 2022 Jul; 47(8):1574-1581. PubMed ID: 35046508
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chinese My Trauma Recovery, a Web-based intervention for traumatized persons in two parallel samples: randomized controlled trial.
    Wang Z; Wang J; Maercker A
    J Med Internet Res; 2013 Sep; 15(9):e213. PubMed ID: 24080137
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treating nightmares in posttraumatic stress disorder with dronabinol: study protocol of a multicenter randomized controlled study (THC PTSD-trial).
    Roepke S; Schoofs N; Priebe K; Wülfing F; Schmahl C; Röhle R; Zähringer J; Lotter T; Otte C; Koglin S
    BMC Psychiatry; 2023 May; 23(1):319. PubMed ID: 37147642
    [TBL] [Abstract][Full Text] [Related]  

  • 69. N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.
    Berk M; Copolov D; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Judd F; Katz F; Katz P; Ording-Jespersen S; Little J; Conus P; Cuenod M; Do KQ; Bush AI
    Biol Psychiatry; 2008 Sep; 64(5):361-8. PubMed ID: 18436195
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study.
    Hoffer ME; Balaban C; Slade MD; Tsao JW; Hoffer B
    PLoS One; 2013; 8(1):e54163. PubMed ID: 23372680
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study.
    Tse HN; Raiteri L; Wong KY; Yee KS; Ng LY; Wai KY; Loo CK; Chan MH
    Chest; 2013 Jul; 144(1):106-118. PubMed ID: 23348146
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial.
    Rae Olmsted KL; Bartoszek M; Mulvaney S; McLean B; Turabi A; Young R; Kim E; Vandermaas-Peeler R; Morgan JK; Constantinescu O; Kane S; Nguyen C; Hirsch S; Munoz B; Wallace D; Croxford J; Lynch JH; White R; Walters BB
    JAMA Psychiatry; 2020 Feb; 77(2):130-138. PubMed ID: 31693083
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Can acetylcysteine ameliorate cisplatin-induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double-blind, placebo-controlled trial involving patients with head and neck cancer.
    Visacri MB; Quintanilha JCF; de Sousa VM; Amaral LS; de F L Ambrósio R; Calonga L; Curi SFBB; de T Leme MF; Chone CT; Altemani JMC; Mazzola PG; Malaguti C; Vercesi AE; Lima CSP; Moriel P
    Cancer Med; 2019 May; 8(5):2020-2030. PubMed ID: 30977273
    [TBL] [Abstract][Full Text] [Related]  

  • 74. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
    Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
    Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluating the Effect of Oral N-acetylcysteine as an Adjuvant Treatment on Clinical Outcomes of Patients with Rheumatoid Arthritis: A Randomized, Double Blind Clinical Trial.
    Batooei M; Tahamoli-Roudsari A; Basiri Z; Yasrebifar F; Shahdoust M; Eshraghi A; Mehrpooya M; Ataei S
    Rev Recent Clin Trials; 2018; 13(2):132-138. PubMed ID: 29521247
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
    Ching TH; Williams MT; Wang JB; Jerome L; Yazar-Klosinski B; Emerson A; Doblin R
    J Psychopharmacol; 2022 Aug; 36(8):974-986. PubMed ID: 35727042
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial.
    Matsuoka Y; Nishi D; Hamazaki K; Yonemoto N; Matsumura K; Noguchi H; Hashimoto K; Hamazaki T
    J Clin Psychiatry; 2015 Aug; 76(8):e1015-22. PubMed ID: 26335087
    [TBL] [Abstract][Full Text] [Related]  

  • 78. S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial.
    Sarris J; Murphy J; Stough C; Mischoulon D; Bousman C; MacDonald P; Adams L; Nazareth S; Oliver G; Cribb L; Savage K; Menon R; Chamoli S; Berk M; Ng CH; Byrne GJ
    Psychopharmacology (Berl); 2020 Jan; 237(1):209-218. PubMed ID: 31712971
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.
    Raskind MA; Peskind ER; Chow B; Harris C; Davis-Karim A; Holmes HA; Hart KL; McFall M; Mellman TA; Reist C; Romesser J; Rosenheck R; Shih MC; Stein MB; Swift R; Gleason T; Lu Y; Huang GD
    N Engl J Med; 2018 Feb; 378(6):507-517. PubMed ID: 29414272
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder.
    Dean OM; Gray KM; Villagonzalo KA; Dodd S; Mohebbi M; Vick T; Tonge BJ; Berk M
    Aust N Z J Psychiatry; 2017 Mar; 51(3):241-249. PubMed ID: 27316706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.